TY - JOUR
T1 - Which primary organ is most suitable for performing pulmonary metastasectomy?
AU - Hirai, Fumihiko
AU - Kinoshita, Ikuhiko
AU - Matsubara, Taichi
AU - Haratake, Naoki
AU - Kouzuma, Yuka
AU - Takamori, Shinkichi
AU - Akamine, Takai
AU - Toyokawa, Gouji
AU - Tagawa, Tetsuzo
AU - Takenoyama, Mitsuhiro
AU - Maehara, Yoshihiko
N1 - Publisher Copyright:
© 2018 International Institute of Anticancer Research. All rights reserved.
PY - 2018/2
Y1 - 2018/2
N2 - Background/Aim: The aim of this study was to assess the appropriateness of pulmonary metastasectomy (MT), with a focus on the primary organ. Patients and Methods: The pathological status of the primary organ, outcome of the MT, disease-free interval, and overall survival were assessed. Results: The primary organ was the most significant prognostic factor analyzed, with a relative risk of 4.6 (95% confidence interval: 1.69-12.56, p=0.003). Patients with colorectal carcinoma had a better survival than those with another primary organ (p=0.003). The hazard ratios by primary organ in comparison to colorectal carcinoma were 3.2 for head and neck carcinoma, 3.5 for soft tissue sarcoma, 8.3 for hepatocellular carcinoma, and 8.9 for urinary carcinoma. Conclusion: Colorectal carcinoma is associated with a greater survival benefit than cancer of other primary organs. Colorectal carcinoma cases should be more aggressively considered for MT than other primary organ cases.
AB - Background/Aim: The aim of this study was to assess the appropriateness of pulmonary metastasectomy (MT), with a focus on the primary organ. Patients and Methods: The pathological status of the primary organ, outcome of the MT, disease-free interval, and overall survival were assessed. Results: The primary organ was the most significant prognostic factor analyzed, with a relative risk of 4.6 (95% confidence interval: 1.69-12.56, p=0.003). Patients with colorectal carcinoma had a better survival than those with another primary organ (p=0.003). The hazard ratios by primary organ in comparison to colorectal carcinoma were 3.2 for head and neck carcinoma, 3.5 for soft tissue sarcoma, 8.3 for hepatocellular carcinoma, and 8.9 for urinary carcinoma. Conclusion: Colorectal carcinoma is associated with a greater survival benefit than cancer of other primary organs. Colorectal carcinoma cases should be more aggressively considered for MT than other primary organ cases.
UR - http://www.scopus.com/inward/record.url?scp=85041672533&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85041672533&partnerID=8YFLogxK
U2 - 10.21873/anticanres.12320
DO - 10.21873/anticanres.12320
M3 - Article
C2 - 29374738
AN - SCOPUS:85041672533
SN - 0250-7005
VL - 38
SP - 1041
EP - 1045
JO - Anticancer research
JF - Anticancer research
IS - 2
ER -